Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma"

Affiliations

• ¹ Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, CT 06520, USA.
• ² Department of Biomedical Sciences, Korea University College of Medicine, 02841 Seoul, Republic of Korea.
• ³ Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA.
• ⁴ Department of Pathology, Yale University School of Medicine, CT 06520, USA.
• ⁵ Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, CT 06520, USA. Electronic address: alessandro.santin@yale.edu.